Hypertension has been associated with raised plasma levels of complement factor 3 and 4 (C3 and C4). The nature of this association is unclear. This populationbased longitudinal study explored whether C3 or C4 is associated with development of hypertension. Blood pressure and plasma levels of C3 and C4 were determined in 2178 healthy men, aged 35-50 years, initially without treatment for hypertension. Incidence of hypertension and blood pressure increase over 15.7 (72.2) years follow-up was studied in relation to C3 and C4 at baseline. Among men with initially normal blood pressure (o160/95 mm Hg), incidence of hypertension (X160/95 mm Hg or treatment) was 32, 42, 37 and 47%, respectively, for men with C3 in the first, second, third and fourth quartile (trend: P ¼ 0.001). This relationship remained significant after adjustment for confounding factors. Among men without blood pressure treatment, systolic BP increase (mean þ standard error, adjusted for age, initial blood pressure and follow-up time) was 17.5 þ 0.8, 19.6 þ 0.9, 19.8 þ 0.8 and 20.8 þ 0.8 mm Hg, respectively, in the C3 quartiles (trend: P ¼ 0.004). C3 was not associated diastolic blood pressure at followup. Although C4 was associated with blood pressure at the baseline examination, there was no relationship between C4 and development of hypertension or future blood pressure increase. It is concluded that C3 in plasma is associated with future blood pressure increase and development of hypertension.
Introduction
The relationship between age and increasing blood pressure is well documented. A study from the Framingham cohort reported that the biennial incidence of hypertension increased from 3.3% in 30 to 39 year-old men to 6.2% in men aged 70-79 years. 1 However, the reasons and risk factors for the age-related increase in blood pressure are incompletely known. Recent studies suggest that lowgrade inflammation could be a new risk factor for incidence of hypertension. [2] [3] [4] [5] Complement factor 3 and 4 (C3 and C4) are acute phase proteins, which are synthesized by stimulation of proinflammatory cytokines. [6] [7] [8] Although the hepatic synthesis is most important, it has been shown that many cell types, including vascular cells, 9 can produce C3. C3 and C4 and other complement components are retained and activated in atherosclerotic lesions [10] [11] [12] [13] and complement activation could have an important role in atherogenesis. [10] [11] [12] [13] [14] High concentrations of C3 have been associated with incidence of myocardial infarction. 15 Obesity, insulin resistance and diabetes are associated with raised plasma concentrations of C3 and C4. [16] [17] [18] [19] Several links of evidence suggest that C3 also could be related to hypertension. Cross-sectional studies have reported raised C3 concentrations in subjects with hypertension. 18, 20 Elevated levels of C3 and C4 have been reported in hypertensives with left ventricular hypertrophy. 21 It has been reported that the frequency of the C3F variant differ between hypertensive patients and normotensive controls. 22 A recent study of spontaneously hypertensive rats reported that C3 was produced by arterial smooth muscle cells, and importantly, that C3 stimulated the exaggerated growth of these cells. 23 However, to the best of our knowledge, no study has explored whether C3 or C4 predict the development of hypertension.
The purpose of this longitudinal cohort study was to explore whether C3 and C4 are associated with the development of hypertension.
Methods

Study cohort
The study cohort has previously been used to explore the relationship between five inflammatory proteins and incidence of hypertension, and was described in detail in that article. 4 Between 1974 and 1984, 22 444 men participated in a screening programme for detection of individuals with high risk for cardiovascular diseases. 24, 25 Participation rate was 71%. Determination of plasma proteins was part of the programme for 6193 men, selected at random from cohorts examined between 1974 and 1982. After the exclusion of men with a history of myocardial infarction, stroke or cancer (n ¼ 118), men without information about C3 (n ¼ 216), men with pharmacological treatment for hypertension (n ¼ 273) and missing information on blood pressure (n ¼ 4), 5582 men remained.
Between 1991 and 1996, approximately 40% of all 45-to 73-year-old men in the city were examined as a part of the Malmö Diet and Cancer study. 26 Of the 5582 with data on C3, 393 died before the follow-up period, and 967 were not invited as they moved away from the city or belonged to non-eligible age groups. A total of 4222 men were invited to the follow-up, 2178 (52%) of them participated.
Age at baseline ranged between 35 and 50 years. Mean follow-up was 15.772.2 years (range 9.5-21.5).
Compared to invited men who did not participate in the follow-up examination (n ¼ 2044), the present study cohort (n ¼ 2178) had somewhat lower C3 (0.99 vs 1.02 g/l) and systolic blood pressure (SBP) (127.5 vs 128.4 mm Hg), whereas age was similar in the groups (46.5 vs 46.4 years). Mean C3 and SBP in men who died during the follow-up period was 1.0370.23 g/l and 131717 mm Hg, respectively.
Examinations
Subjects were categorized into daily smokers and non-smokers at baseline and at follow-up. Blood samples were taken at the baseline examination after an overnight fast and analysed at the laboratory of the university hospital. Serum cholesterol and blood glucose was analysed with standard methods. At baseline, men with fasting blood glucose X6.7 mmol/l and men who reported receiving treatment for diabetes were considered to have diabetes.
Height and weight was measured at both examinations. Body mass index (BMI) at baseline was calculated as weight/height 2 (kg/m 2 ). Weight increase was calculated as weight at baseline subtracted from the follow-up value. The waist (cm) and hip circumferences (cm) were measured by a trained nurse at the follow-up. 26 Alcohol consumption was assessed at the follow-up examination. A menu book was used to record intake of alcoholic beverages during seven consecutive days. 26 Alcohol consumption (g/week) was log transformed before analysis because of the skew distribution.
Education level and cohabiting status was assessed in a questionnaire at the follow-up examination. Education was divided into men who received a high school diploma or less (n ¼ 1569) and men with college degree or more (n ¼ 606). The sample was divided into men living alone (n ¼ 344) and men who lived with a partner (n ¼ 1808). Information on education or cohabiting status was missing for three and 26 men, respectively.
C3 and C4
An electroimmunoassay method was used to assess the concentrations of plasma proteins. 27 The analysis was performed consecutively at the study entry. The coefficient of variation was o5%.
27 C3 and C4 were originally expressed as the percentage of the mean values from a reference population of blood donors. The reference values for C3 were 70-130%, which corresponds to 0.67-1.29 g/l, and the reference values for C4 were 65-170% (0.13-0.32 g/l). In order to facilitate the interpretation of the C3 and C4 values, the percentages have been converted into g/l (C3: 100% ¼ 0.98 g/l, C4: 100% ¼ 0.20 g/l). The distribution of the other plasma proteins (fibrinogen, haptoglobin, ceruloplasmin, orosomucoid, a1-antitrypsin) have been presented previously. 4, 19, 25 Blood pressure Blood pressure (mm Hg) was measured to the nearest 5 mm Hg after a 10-min rest, with the subject in a horizontal position. A sphygmomanometer and a rubber cuff of appropriate size was used. At the follow-up examination, blood pressure was measured once after a 5-min rest. The same equipment was used at both examinations. Pulse pressure (PP) was calculated as the difference between SBP and diastolic blood pressure (DBP). Blood pressure increase (DSBP, DDBP and DPP) was calculated by subtracting the baseline value from the follow-up value.
Blood pressure medication was assessed in a questionnaire at baseline. At the follow-up examination, blood pressure medication was assessed in a questionnaire and by asking the participants to bring all medicines to the examination. Hypertension was defined as SBP or DBP X160/95 mm Hg or medical treatment for hypertension. 28 In an additional analysis, incidence of hypertension was explored using a lower definition of hypertension (X140/90 mm Hg or treatment). 29 
Statistics
The relationships between development of hypertension and C3, C4 and other risk factors was assessed by means of logistic regression. One-way analysis of variance was used to assess the linear trends of blood pressure and blood pressure increase by quartile of C3 and C4. This model was extended to a general linear model in order to adjust the relationships for confounding factors. In the first model, the relationships were adjusted for age, baseline blood pressure and follow-up time. In the second model, the relationships were adjusted for factors associated with development of hyperten-sion in the univariate analysis. Interaction terms were added to the models in order to assess possible interactions.
Results
Study cohort
All men in the study cohort (n ¼ 2178) were without antihypertensive treatment at baseline (exclusion criteria). A total of 1719 men were without antihypertensive treatment both at baseline and follow-up, and this group was used to study the relationships between C3 and future blood pressure. A total of 1726 men had normal blood pressure at baseline (o160/95 mm Hg), and this group was used to study incidence of hypertension. Table 1 presents the risk factors in men with and without hypertension at follow-up.
C3 and blood pressure increase
Among men who were without antihypertensive treatment at both examinations (n ¼ 1719), SBP and DBP were significantly associated with C3, both at baseline and follow-up (Table 2) .
After adjustment for follow-up time, age and blood pressure at baseline, C3 was significantly related to increase in DSBP and DPP (Table 2 ). This trend persisted after adjustments for potential risk factors for hypertension (DSBP: P ¼ 0.02, DPP: P ¼ 0.01). Further adjustment for C4 and other inflammatory markers (fibrinogen, haptoglobin, ceruloplasmin, orosomucoid, a1-antitrypsin) did not change the results (not shown, DSBP: P ¼ 0.02, DPP:
At the follow-up examination, 66 men used aspirin and 37 used cholesterol-lowering statins. There was no significant relationship between C3 and these drugs and adjustment for these drugs did not change the results.
During the follow-up period, there were big variations in blood pressure increase, and blood pressure generally increased most in those who initially had low blood pressures. Table 3 presents the relationship between C3 and blood pressure at follow-up among men with baseline SBP, DBP and PP below or above median. Among those with low BP at baseline, the follow-up values of all three blood pressure indices were significantly related to C3, after adjustments for age, follow-up time and initial blood pressure. There were no significant relationships with C3 among those with high BP at baseline. For SBP and DBP, there were statistically significant interaction terms between baseline blood pressure and C3 quartile on future blood pressure level.
Incidence of hypertension A total of 1726 men had normal blood pressure at baseline (o160/95 mm Hg and no treatment for hypertension). In this group, 675 men had hypertension at the follow-up examination. The proportion with hypertension at follow-up was significantly higher in men with C3 in the top quartile (Table 4) . This relationship persisted after adjustments for confounding factors (trend: P ¼ 0.01). The results remained significant after further adjustments for C4 and other inflammatory markers (not shown). The other significant predictors of hypertension in the final model were age (OR per year:1.06, CI:1.01-1.11), weight gain (OR per kg:1.04, CI:1.02-1.06), initial SBP (OR per mm Hg: 1.06, CI:1.05-1.08) and waist-hip ratio (OR per 0.1 units:1.35, CI:1.07-1.71).
The relationship with incidence of hypertension was mainly explained by increased incidence of untreated hypertension. No clear relationship was found between C3 and blood pressure treatment at follow-up (Table 4) .
A total of 66 men had a myocardial infarction during the follow-up period. The analysis was rerun after excluding these subjects. The relationship between C3 and incidence of hypertension remained significant (trend: P ¼ 0.008).
The relationship between C3 and incidence of hypertension was also explored using a lower definition for hypertension (X140/90 mm Hg or treatment). With this definition of hypertension, At follow-up, blood pressure was still higher in men with high C4. However, after adjustment for blood pressure at baseline, age and follow-up time, there was no relationship between C4 and blood pressure at follow-up (not shown). There was neither any significant relationship between C4 and development of hypertension. 
Discussion
In this population-based cohort, almost 40% of the men with normal blood pressure developed hypertension over 15 years of follow-up. As expected, incidence of hypertension was associated with age, waisthip ratio and weight gain. However, C3 in plasma was another risk factor for hypertension. This relationship, which is reported for the first time, persisted after adjustment for other risk factors. C4 was associated with blood pressure at baseline, but showed no relationship with development of hypertension. The reasons for the relationships between C3 and incidence of hypertension are unclear. Recent studies have shown that raised plasma concentration of different inflammatory markers is associated with the development of hypertension. [2] [3] [4] [5] However, the correlations between C3 and other acute-phase proteins are moderate or small 18, 19 (all ro0.30 in this study), and C3 was associated with hypertension even after adjustment for other acute-phase proteins. This suggests that C3 could be associated with development of hypertension through other pathways than low-grade inflammation.
In a study of women with systemic lupus erythematosus, C3 was associated with vascular stiffness, as measured by the pulse wave velocity, 30 independently of other inflammatory markers. In the present study, C3 showed significant relationships with future SBP and pulse pressure, and no clear relationships with DBP. In contrast to DBP, both pulse pressure and SBP are markers of arterial stiffness. It is possible that men with high C3 developed more atherosclerosis, and thereby more arterial stiffness. Many studies support a role of complement activation in atherogenesis. 10, 11 Complement deposition in arterial lesions 12 and gene expression of complement components in arterial plaque 13 have been demonstrated. Studies of mice with C3 deficiency have shown that complement activation play a role in the maturation of atherosclerotic lesions beyond the foam cell stage.
14 However, it is also possible that C3 is associated with blood pressure through causes other than atherosclerosis. C3 has been associated with the growth and development of the vascular smooth muscle cells in animal experiments. A study of spontaneously hypertensive rats showed that C3 stimulated the exaggerated growth of vascular smooth muscle cells, independently of other complement factors. 23 Acylation stimulating protein (ASP) is produced by cleavage of C3. 31 ASP is a metabolically active molecule and has been associated with increased glucose uptake and fatty acid storage in the adipose tissue. Knockout mice with deficiency of C3 and ASP have shown resistance to weight gain, despite increased food intake. 31 However, there is limited data about the relationships between ASP and hypertension. Whether ASP could play a role for the relationship between C3 and hypertension is unclear.
C3 is associated with overweight and obesity, [16] [17] [18] [19] [20] 32, 33 which is one of the most important risk factors for hypertension. A recent study of risk factor treatment reported that weight loss reduced the C3 levels. 32 However, reduction of blood pressure had no effect on C3 levels, which suggest that blood pressure per se probably do not cause C3 elevation. 32 As BMI, waist to hip ratio, weight gain and diabetes were taken into account in the analysis, it is unlikely that these factors explain the relationship with hypertension. Because smoking is associated with low blood pressure, and blood pressure often increases after smoking cessation, smoking is another possible confounder in studies of hypertension. However, the correlation between C3 and smoking is weak, both in this and in other studies, 20 and the results remained after adjustment both for smoking at baseline and at follow-up. We cannot rule out, however, that there could be residual Odds ratio (95% confidence interval) adjusted for age, follow-up time, systolic blood pressure at baseline. c +Cholesterol, BMI at baseline, smoking at follow-up, WHR at follow-up, weight increase during follow-up, education.
C3 and incidence of hypertension G Engström et al confounding or unmeasured risk factors that contribute to the relation between C3 and blood pressure. Population-based studies from the city of Malmö have shown that a majority of hypertensive subjects are untreated, and that the proportion with uncontrolled hypertension is very high among those with blood pressure treatment. 34 It is therefore not surprising that the relationship between C3 and hypertension was explained by increased incidence of untreated hypertension, and that no clear association was observed with blood pressure treatment. However, it is also likely that men with treated hypertension, who already visit a doctor regularly, more often were non-participants at the re-examination.
Mortality during the long follow-up period is another potential cause of bias. Both C3 and blood pressure were higher in those who died during the follow-up period, and levels were somewhat higher in those who did not participate in the re-examination. Because hypertension is associated with premature mortality, this would reduce the longitudinal associations between C3 and blood pressure. Because of the study design, we cannot claim that the study cohort is representative for the entire sample population, and the results are thus based on the internal validity of the cohort.
The relationship between C3 and blood pressure increase was observed in those with normal blood pressure at baseline, and not in men who initially had high pressures. Higher mortality during followup among men with high blood pressure, and lower participation rates among men with blood pressure treatment could explain this relationship. However, although speculative, it cannot be ruled out that C3 may be a risk factor for mild or moderate hypertension, whether other risk factors could be needed for the development of very high pressures.
Misclassification of exposure is a potential cause of bias in epidemiological studies. Blood pressure often shows large variations and several repeated measurements should ideally be performed to reduce misclassification. However, such misclassification would, if anything, dilute the relationships between C3 and blood pressure. The association between ISP and blood pressure increase was statistically significant even though only one measurement was performed at baseline and follow-up.
It is concluded that plasma C3, but not C4, is associated with the development of hypertension.
